Your browser doesn't support javascript.
loading
Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
Li, Chunxiao; Xu, Tao; Zhou, Peng; Zhang, Junhua; Guan, Ge; Zhang, Hui; Ling, Xiao; Li, Weixia; Meng, Fei; Liu, Guanping; Lv, Linyan; Yuan, Jun; Li, Xuelin; Zhu, Mingjun.
Afiliação
  • Li C; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Xu T; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Zhou P; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Zhang J; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, People's Republic of China.
  • Guan G; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Zhang H; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Ling X; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Li W; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Meng F; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China.
  • Liu G; Guangxi Wuzhou Pharmaceutical (group) Co., Ltd, Wuzhou, 543000, People's Republic of China.
  • Lv L; Guangxi Wuzhou Pharmaceutical (group) Co., Ltd, Wuzhou, 543000, People's Republic of China.
  • Yuan J; Shanghai Yongzheng Medical Science and Technology Co., Ltd, Shanghai, 200000, People's Republic of China.
  • Li X; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China. lixuelin450000@163.com.
  • Zhu M; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, People's Republic of China. zhumingjun317@163.com.
BMC Complement Altern Med ; 18(1): 277, 2018 Oct 16.
Article em En | MEDLINE | ID: mdl-30326892
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vigilância de Produtos Comercializados / Medicamentos de Ervas Chinesas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: BMC Complement Altern Med Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vigilância de Produtos Comercializados / Medicamentos de Ervas Chinesas / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: BMC Complement Altern Med Assunto da revista: TERAPIAS COMPLEMENTARES Ano de publicação: 2018 Tipo de documento: Article